A A F Carioca1, S M M L Verde1,2, L A Luzia1, P H C Rondó1, M R D O Latorre3, T H P Ellery1, N R T Damasceno1. 1. Department of Nutrition, School of Public Health, University of São Paulo, São Paulo, Brazil. 2. Nutrition course, University of Fortaleza, Fortaleza, Brazil. 3. Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo, Brazil.
Abstract
BACKGROUND/ OBJECTIVES: Breast cancer is a disease characterised by both oxidative reactions and inflammation. However, few studies have focused on the oxidative and inflammatory biomarkers. The aim of the present study was to evaluate the association between oxidative stress markers and adiposity and clinical staging, as well as the association between the oxidative and the antioxidant biomarkers of women with breast cancer. SUBJECTS/ METHODS: A total of 135 cases of breast cancer occurring in 2011 and 2012 were assessed. After exclusions, 101 pre- and post-menopausal women with clinical staging I to IV were eligible to participate in the study. The anthropometric evaluation was performed by collecting data on waist circumference, body mass index and body composition. The socioeconomic and clinical profiles were determined using a standard questionnaire. For the oxidative biomarkers, thiobarbituric acid reactive substances (TBARS), oxidative DNA damage (8-hydroxy-2-deoxyguanosine (8-OHdG)), low-density lipoprotein(-) (LDL(-)), autoantibody anti-LDL(-) and liposoluble antioxidants (α-tocopherol, retinol and β-carotene) were analysed. The data were analysed using differences in the mean values, correlation tests and multiple linear regression. RESULTS: The antioxidant levels were higher in postmenopausal women with clinical staging I and II and negative lymph nodes. The TBARS level was associated with clinical staging. Adiposity was associated with levels of retinol and 8-OHdG, whereas LDL(-), 8-OHdG and TBARS were correlated with liposoluble antioxidants after adjusting for the confounders. CONCLUSIONS: The adiposity and clinical staging of patients were associated with oxidative stress. The oxidative and antioxidant biomarkers showed a negative correlation in patients with breast cancer.
BACKGROUND/ OBJECTIVES:Breast cancer is a disease characterised by both oxidative reactions and inflammation. However, few studies have focused on the oxidative and inflammatory biomarkers. The aim of the present study was to evaluate the association between oxidative stress markers and adiposity and clinical staging, as well as the association between the oxidative and the antioxidant biomarkers of women with breast cancer. SUBJECTS/ METHODS: A total of 135 cases of breast cancer occurring in 2011 and 2012 were assessed. After exclusions, 101 pre- and post-menopausal women with clinical staging I to IV were eligible to participate in the study. The anthropometric evaluation was performed by collecting data on waist circumference, body mass index and body composition. The socioeconomic and clinical profiles were determined using a standard questionnaire. For the oxidative biomarkers, thiobarbituric acid reactive substances (TBARS), oxidative DNA damage (8-hydroxy-2-deoxyguanosine (8-OHdG)), low-density lipoprotein(-) (LDL(-)), autoantibody anti-LDL(-) and liposoluble antioxidants (α-tocopherol, retinol and β-carotene) were analysed. The data were analysed using differences in the mean values, correlation tests and multiple linear regression. RESULTS: The antioxidant levels were higher in postmenopausal women with clinical staging I and II and negative lymph nodes. The TBARS level was associated with clinical staging. Adiposity was associated with levels of retinol and 8-OHdG, whereas LDL(-), 8-OHdG and TBARS were correlated with liposoluble antioxidants after adjusting for the confounders. CONCLUSIONS: The adiposity and clinical staging of patients were associated with oxidative stress. The oxidative and antioxidant biomarkers showed a negative correlation in patients with breast cancer.
Authors: V J Victorino; C Panis; F C Campos; R C Cayres; A N Colado-Simão; S R Oliveira; A C S A Herrera; A L Cecchini; R Cecchini Journal: Age (Dordr) Date: 2012-05-28
Authors: Laura Vera-Ramirez; Pedro Sanchez-Rovira; M Carmen Ramirez-Tortosa; Cesar L Ramirez-Tortosa; Sergio Granados-Principal; Jose A Lorente; Jose L Quiles Journal: Crit Rev Oncol Hematol Date: 2011-02-01 Impact factor: 6.312
Authors: María Jesús Ramírez-Expósito; Estefanía Sánchez-López; Cristina Cueto-Ureña; Basilio Dueñas; Pilar Carrera-González; Joaquín Navarro-Cecilia; María Dolores Mayas; José M Arias de Saavedra; Rafael Sánchez-Agesta; José M Martínez-Martos Journal: Exp Gerontol Date: 2014-07-11 Impact factor: 4.032
Authors: Karma C Fussell; Ronald G Udasin; Peter J S Smith; Michael A Gallo; Jeffrey D Laskin Journal: Carcinogenesis Date: 2011-06-10 Impact factor: 4.944
Authors: C Panis; V J Victorino; A C S A Herrera; L F Freitas; T De Rossi; F C Campos; A N Colado Simão; D S Barbosa; P Pinge-Filho; R Cecchini; A L Cecchini Journal: Breast Cancer Res Treat Date: 2011-11-03 Impact factor: 4.872
Authors: Cara L Frankenfeld; Johanna W Lampe; Jackilen Shannon; Dao L Gao; Wenjin Li; Roberta M Ray; Chu Chen; Irena B King; David B Thomas Journal: Public Health Nutr Date: 2011-06-06 Impact factor: 4.022
Authors: Letícia L D Santos; Isis D D Custódio; Alinne T F Silva; Izabella C C Ferreira; Eduarda C Marinho; Douglas C Caixeta; Adriele V Souza; Renata R Teixeira; Thaise G Araújo; Nitin Shivappa; James R Hébert; Carlos Eduardo Paiva; Foued S Espíndola; Luiz Ricardo Goulart; Yara C P Maia Journal: Nutrients Date: 2020-10-28 Impact factor: 5.717